ISO 9001 CERTIFIED QMS · UKAS-VERIFIED THIRD-PARTY TESTING · HPLC-VERIFIED PER BATCH
✓ HPLC-verified per batch ✓ CoA with every order ✓ 2-3 day Ireland delivery ✓ ISO 9001 certified

PRODUCTS SOLD ON PEPTIDESLABIRELAND.COM ARE FOR RESEARCH PURPOSES ONLY AND ARE NOT FOR HUMAN OR VETERINARY USE.

Fast Ireland delivery — dispatched to Dublin, Cork, Galway, Limerick and nationwide.

Follistatin and Myostatin Pathway Research — Ireland Reference (2026)

By the Peptides Lab Ireland research team · Updated July 2026 · Research use only

The Follistatin–Myostatin (GDF-8) pathway is one of the most active areas of muscle biology research and a central axis in negative-regulator biology of skeletal muscle. This reference explains the pathway and the three research compounds Irish research groups use to study it.

What is myostatin (GDF-8)?

Myostatin : also called GDF-8 (Growth/Differentiation Factor 8) , is a member of the TGF-β superfamily and functions as a negative regulator of skeletal muscle mass. Genetic knockout of myostatin in animal models produces dramatic muscle hypertrophy, and rare natural mutations in cattle and humans (the “double-muscled” phenotype) have been characterised.

What is Follistatin?

Follistatin is a glycoprotein that binds and neutralises myostatin (as well as activin). By sequestering myostatin, Follistatin removes the brake on muscle growth. It is the canonical research reference for myostatin pathway inhibition.

What is ACE-031?

ACE-031 is a soluble activin receptor type IIB (ActRIIB) fusion protein research reference. Rather than binding myostatin directly (like Follistatin), it acts as a decoy receptor — myostatin binds to the soluble ActRIIB and can’t engage the real membrane receptor.

The three research approaches to studying myostatin pathway

Compound Mechanism Best research fit
GDF-8 (myostatin) Endogenous protein — study the ligand itself Baseline pathway biology, receptor pharmacology
Follistatin Binds and neutralises myostatin (and activin) Ligand-sequestration research
ACE-031 Soluble ActRIIB decoy receptor Receptor-level pathway inhibition research

Research applications

Preclinical research using these compounds covers:

  • Skeletal muscle hypertrophy models
  • Sarcopenia (age-related muscle loss) research
  • Cachexia (disease-related muscle wasting) research
  • Satellite cell activation biology
  • Muscular dystrophy model research
  • Comparative studies against IGF-1 axis compounds (see IGF-1 LR3, MGF)

Related research compounds worth knowing

  • IGF-1 LR3 modified IGF-1 analogue (positive-regulator side)
  • MGF (Mechano Growth Factor) , with IGF-1 splice variant central to muscle regeneration
  • PEG-MGF : PEG-modified extended-half-life MGF

Reconstitution

All three compounds reconstitute with bacteriostatic water see our reconstitution guide. Follow batch-specific stability guidance on the COA. Large proteins (Follistatin, ACE-031) benefit from extra-gentle reconstitution technique — swirl gently, don’t shake.

Regulatory context

None of these compounds is approved as a medicinal product in Ireland. Supplied strictly for in-vitro laboratory research and see our HPRA guide.

Sourcing in Ireland

Further reading

For laboratory research use only. Not intended for human or veterinary use.

Picture of Emma Louise

Emma Louise

Chief Compliance Officer at Peptides Lab Ireland. Emma Louise leads regulatory compliance, HPRA framework interpretation, batch quality documentation and editorial standards for the Peptides Lab Ireland research reference library. All research guides are reviewed under her editorial oversight.
99% Purity Guarantee
Trusted By Researchers
★★★★★
Celebrating 500,000 Orders
Third party verified

Receive News

Subscribe for the Updates!